Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07304505 · ClinicalTrials.gov registry record · NA
Probiotics in Adults With Rheumatoid Arthritis
A NA study of Rheumatoid Arthritis (RA), sponsored by Ancilia Biosciences.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07304505: Recruiting NA study of Rheumatoid Arthritis (RA), sponsored by Ancilia Biosciences.
NCT07304505 is a NA study of Rheumatoid Arthritis (RA) that is actively recruiting participants, run by Ancilia Biosciences. The registered enrollment target is 50 participants, below the 265-participant average among 17 other Rheumatoid Arthritis (RA) trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07304505, a NA study of Rheumatoid Arthritis (RA), is actively recruiting participants, sponsored by Ancilia Biosciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical study is to collect data on the effect of probiotic administration on clinical outcomes in rheumatoid arthritis patients. Participants will: * Have a 6-week daily administration of a probiotic * Collect fecal samples every other day during the first 3 weeks of the study and twice weekly over the last 3 weeks * Visit the clinic at Baseline, Week 3 and Week 6 for checkup and testing
Primary Outcome
Change from baseline (Day 0) to Day 39 (including intermediate time points) in the relative abundance and/or detection frequency of the administered probiotic strain in stool
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Align Extra Strength Probiotic Supplement
Study Locations (1)
Illinois
- Atlantia Clinical Trials - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-11-13 |
| Est. Completion | 2026-03 |
| Phase | NA |
What NCT07304505 shows while recruiting
NCT07304505 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 265-participant average among 17 other Rheumatoid Arthritis (RA) trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Rheumatoid Arthritis (RA) appearing as the primary indexed condition, and to 1 intervention - of which Align Extra Strength Probiotic Supplement is the first listed.
NCT07304505 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT07304505 about?
NCT07304505 is a clinical study titled "Probiotics in Adults With Rheumatoid Arthritis". The goal of this clinical study is to collect data on the effect of probiotic administration on clinical outcomes in rheumatoid arthritis patients. Participants will: * Have a 6-week daily administration of a probiotic * Collect fecal samples every other day during the first 3 weeks of the study a...
What is the current status of trial NCT07304505?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-11-13. Estimated completion is 2026-03.
What conditions does trial NCT07304505 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis (RA).
What interventions are being tested in trial NCT07304505?
The interventions under investigation include: Align Extra Strength Probiotic Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07304505?
This trial is sponsored by Ancilia Biosciences, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07304505 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis (RA)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07304505's enrollment target sits among peer trials
50 13th of 17 higher than 5 of 17 other Rheumatoid Arthritis (RA) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis (RA) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study]
RECRUITING · NA
-
Dose Response of Exercise for Arthritis Management
RECRUITING · NA
-
Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-Being
RECRUITING · NA
-
Comparative Effectiveness of Primary Care Providers Trained in Rheumatoid Arthritis Management Versus Rheumatologist Care: A Randomized Controlled Trial
RECRUITING · NA
-
Food Trial to Evaluate the Kinetics of the Medical Foods SBD111 and SBD121 Persistence in Healthy Adults
ACTIVE NOT RECRUITING · NA
-
A Trial of Academic Detailing to Promote Prescribing of Biosimilars
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI